A Retrospective Study of Hepatic Arterial Infusion Chemotherapy Combined with Tyrosine Kinase Inhibitors and PD-1 Inhibitors in Hepatocellular Carcinoma Patients with Main Portal Vein Tumor Thrombus (VP4)
The combination of HAIC, TKI, and PD-1 inhibitor demonstrates encouraging antitumor activity and a manageable safety profile in patients with Vp4 HCC, indicating its potential as an effective treatment option for this clinically challenging population.
Authors
- Weifu Liu
- Zhuting Fang (ORCID: https://orcid.org/0000-0003-3350-2210)
- Xiaolong Wang
- Wenchang Yu
- Shiguang Chen
Institutions
- Fujian Medical University (CN)
- Fujian Provincial Cancer Hospital (CN)
Publication Details
- Journal
- Journal of Hepatocellular Carcinoma
- Published
- 2026-01-01
- DOI
- https://doi.org/10.2147/jhc.s562766
- Primary Topic
- Hepatocellular Carcinoma Treatment and Prognosis
- Type
- article
- Field-Weighted Citation Impact
- 0.00